Panitumumab for Colorectal Cancer User Reviews
Brand names: Vectibix
Panitumumab has an average rating of 5.2 out of 10 from a total of 6 reviews for the treatment of Colorectal Cancer. 50% of reviewers reported a positive experience, while 50% reported a negative experience.
- Alaska...
- Taken for 1 to 6 months
- July 24, 2023
"All tumors gone - way better results than expected. Rash / skin conditions small price to pay. Who doesn't want a second chance at puberty?"
- Glenn...
- March 29, 2016
Vectibix (panitumumab) "Its bad enough to have cancer, but this drug doesn't work and turns patients into lepers"
- Anonymous
- Taken for 1 to 6 months
- December 27, 2017
Vectibix (panitumumab) "Have been on this 8-2017 and my CEA marker is down from 16.1 to 3.6. Side effect of dry skin is tolerable."
- Anonymous
- Taken for 1 to 6 months
- November 8, 2017
Vectibix (panitumumab) "This medication has my carcinoembryonic antigen (CEA) test numbers way down . I hate the rash but at least I'm alive."
Are you taking this medicine?
- worst...
- August 30, 2016
"would not recommend this drug to anyone, terrible experience, ended up having a heart attack besides, never had heart problems until taking this drug!!!!"
- Anonymous
- Taken for 6 months to 1 year
- November 29, 2022
"I have horrible skin rashes over my entire body. Also cause infections on my toes that nothing seemed to be able to get rid of. I asked my doctor to discontinue use because my skin rashes were so bad."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Colorectal Cancer
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about panitumumab
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Vectibix (panitumumab) "Vectibix reduced my CEA (cancer marker) from 25.2 all the way down to 2.5 within the matter of a few months. The skin reaction SUCKS. Thankfully Ia able to undergo a revolutionary surgery to remove the portion of my liver with the metastatic cancer so I have just recently been able to stop the Vectibix. I am hoping I will get my beautiful skin back."